
This retrospective study of 176 autoimmune rheumatic disease (ARD) patients with suspected cardiac involvement examined the prevalence and impact of left ventricular subendocardium-involved LGE (LGEse). LGEse was present in 13% of patients, associated with reduced LV ejection fraction (50% vs. 60%) and worse outcomes, including higher rates of adverse cardiac events (32% vs. 8%). Multivariable analysis confirmed LGEse as an independent predictor of poor prognosis, emphasizing its clinical significance in ARD-related cardiac assessment.
Like
Save
Share